BioSpace News Archive

Implementation of Kit Check RFID technology enables accuracy and visibility of hospital medications, from the production line to the patient

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX® (daratumumab) in combination with lenalidomide and dexamethasone (Rd) for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant (ASCT).

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced multiple presentations of its innovative programs including sulbactam-durlobactam (ETX2514SUL), zoliflodacin and ETX0282CPDP, during the American Society for Microbiology (ASM) Microbe Conference 2019

Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), today announced that it will present for the first time pre-clinical data from its STimulator of INterferon Genes (STING) antagonist program at The Autoimmunity Conference organized by the Federation of American Societies for Experimental Biology (FASEB) in Pacific Grove, California, from July 7-12, 2019.

Today, The Leona M. and Harry B. Helmsley Charitable Trust announced a $1.7 million grant to 4YouandMe to explore how tracking stress could predict symptoms of Crohn’s disease.

RCOC Also Debuts Updated Summer Vacation/Recreation Guide in Three Languages

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel ophthalmic surgical devices and sustained pharmaceutical therapies, announced today that it has successfully completed the acquisition of DOSE Medical Corporation that was previously announced on June 19, 2019.

Orthopaedic surgeons offer firework safety tips

vTv Therapeutics Inc. (Nasdaq: VTVT) announced today that the first patient has been screened for the phase 2 proof of concept study evaluating the safety and efficacy of azeliragon in patients with mild Alzheimer’s disease and type 2 diabetes.

Cohen Veterans Bioscience (CVB), a translational research public charity organization dedicated to fast-tracking personalized diagnostics and therapeutics for brain health, today provides a progress update on critical post-traumatic stress disorder (PTSD) programs, and issues proceedings from the first State of the Science Summit focused on PTSD.